Prestige Consumer Healthcare opened higher at $44.72, compared with its previous close of $44.17. In the last trading session, the stock traded between $44.01 and $45.48. It showed an upward intraday trend.
An investment of $100 made 5 years ago in Prestige Consumer Healthcare is now worth
$ 71.59
Resulting in a loss of
$ 28.41 (28.41%)
Note: Past profits do not guarantee future returns.
Rating from 1 Analysts
Today's Change
+$1.15 (+2.60%)
Day High
$45.48
Day Low
$44.01
Day Open
$44.72
Prev Close
$44.17
Volume
3,87,896
1W Return
-14.91%
1M Return
-7.44%
3M Return
-15.46%
6M Return
-10.53%
1Y Return
-25.19%
Market Cap ($ Mn)
2,148
PE Ratio
14.70
PB Ratio
1.30
PEG Ratio
65.15
ROE
12.35%
ROCE
10.29%
EPS (TTM)
$0.53
1 Week
-14.91%
1 Month
-7.44%
3 Months
-15.46%
6 Months
-10.53%
9 Months
-31.31%
Canaccord Genuity maintains Buy on Prestige Consumer, cuts target to $70
Canaccord Genuity maintains a Buy rating on Prestige Consumer Healthcare. Price target lowered to $70 from $72 by analyst Susan Anderson.
6 days agoPrestige Consumer Q1FY27 Results: Revenue rises 6.5% to $266 million
Revenue increased 6.5% YoY to $265.7 million in Q1FY27. Adjusted EPS rose to $0.98 from $0.95 in the prior year. Full-year revenue guidance raised to $1.29-$1.315 billion due to acquisitions. Adjusted free cash flow reached a quarterly record of $83.7 million. Gross margin declined 120 bps YoY to ~55%, but guided to >57% for FY27.
1mo agoPrestige Consumer Healthcare to host fireside chat at Barclays Global Consumer Conference
Ron Lombardi and Christine Sacco to lead fireside chat at Barclays Global Consumer Conference. Session scheduled for September 10, 2026, at 12:45 pm ET. Live webcast available via company investor relations website. Replay option will be posted online following the event.
2mo agoPrestige Consumer Healthcare to present at Canaccord Genuity conference
Prestige Consumer Healthcare Inc. executives Christine Sacco and Phil Terpolilli will join a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026. The session, scheduled for 10:00 a.m. ET, will be webcast live and made available as a replay on the company's investor relations website.
3mo agoPrestige Consumer Latest Results: Sales guidance rises to $1.29B-$1.315B
Prestige Consumer Healthcare upgrades its FY2027 adjusted EPS guidance to $4.55-$4.65 and sales outlook to $1.290B-$1.315B, beating analyst estimates of $4.53 and $1.179B respectively.
3mo agoPrestige prices $400 million 6.25% notes due 2034
Prestige Consumer Healthcare Inc. has priced a $400 million offering of 6.25% senior notes due 2034. The senior unsecured obligations, issued by subsidiary Prestige Brands, Inc., will be used to redeem all $400 million of outstanding 5.125% Senior Notes due January 2028. The sale is expected to close on July 15, 2026.
4mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $1,437.29 | +0.35% | $13,52,123.38M | 39.43 | |
| $280.41 | -0.13% | $6,75,033.80M | 31.06 | |
| $294.98 | +0.37% | $5,21,411.37M | 72.17 | |
| $147.18 | -0.59% | $3,62,834.91M | 117.74 | |
| $160.32 | -1.80% | $3,26,222.34M | 23.23 | |
| $185.48 | -0.69% | $2,87,691.54M | 24.32 | |
| $468.11 | +0.62% | $2,53,205.85M | 26.86 | |
| $169.73 | -0.67% | $2,10,522.74M | - | |
| $29.45 | +0.31% | $1,67,860.70M | 36.79 | |
| $41.09 | +0.96% | $1,39,300.36M | 11.15 | |
| $62.91 | +0.18% | $1,28,593.45M | 14.67 | |
| $48.43 | +0.41% | $1,16,984.89M | 23.63 |
An investment of $100 made 5 years ago in Prestige Consumer Healthcare is now worth
$ 71.59
Resulting in a loss of
$ 28.41 (28.41%)
Note: Past profits do not guarantee future returns.
